SCHEMBL12705141

SCHEMBL12705141

CC1OC(=O)CC1OC(=O)C(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.36
PRKCA P17252 6/20 0.35
HMGCR P04035 6/20 0.31
CYP3A4 P08684 4/20 0.31
LMNA P02545 3/20 0.31
HIF1A Q16665 3/20 0.31
ABCB11 O95342 3/20 0.31
KDM4E B2RXH2 2/20 0.31
ITGB2 P05107 2/20 0.31
ICAM1 P05362 2/20 0.31
PGR P06401 2/20 0.31
ABCB1 P08183 2/20 0.31
ADORA3 P0DMS8 2/20 0.31
MAPT P10636 2/20 0.31
ADRB3 P13945 2/20 0.31
ALOX15 P16050 2/20 0.31
TSHR P16473 2/20 0.31
ITGAL P20701 2/20 0.31
TACR2 P21452 2/20 0.31
TBXA2R P21731 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL879064 0.80 HMGCR (0.47) SMN1; SMN2HMGCRCYP3A4LMNAHIF1A
SCHEMBL686256 0.75 SMN1; SMN2 (0.35) SMN1; SMN2PRKCAHMGCRCYP3A4ABCB11
SCHEMBL6743284 0.73 GPX4 (0.40) SMN1; SMN2PRKCAKDM4EMAPTTDP1
SCHEMBL14159897 0.73 PPARG (0.32) SMN1; SMN2HMGCRCYP3A4LMNAHIF1A
SCHEMBL786675 0.72 SMN1; SMN2 (0.32) SMN1; SMN2PRKCAHMGCRCYP3A4ABCB11
SCHEMBL12934474 0.70
SCHEMBL879226 0.70 HMGCR (0.47) SMN1; SMN2HMGCRCYP3A4ABCB11KDM4E
SCHEMBL24385922 0.68 SMN1; SMN2 (0.32) SMN1; SMN2PRKCA
SCHEMBL24385933 0.67 SMN1; SMN2 (0.40) SMN1; SMN2
SCHEMBL24385891 0.67 SMN1; SMN2 (0.40) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110091808-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110091808-A1 PHOTORESIST COMPOSITION ASIC1, ASIC3, SUN2 SMN1; SMN2 4235/4885PRKCA 1157/4885HMGCR 4187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.